VKTX - Viking Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VKTX is currently covered by 7 analysts with an average price target of $95. This is a potential upside of $70.6 (289.34%) from yesterday's end of day stock price of $24.4.

Viking Therapeutics's activity chart (see below) currently has 211 price targets and 188 ratings on display. The stock rating distribution of VKTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50.32% with an average time for these price targets to be met of 402.15 days.

Highest price target for VKTX is $110, Lowest price target is $65, average price target is $95.

Most recent stock forecast was given by EDWARD NASH from CANACCORD. First documented stock forecast 21-Nov-2017.

Best performing analysts who are covering VKTX - Viking Therapeutics:

James Lee Joon Lee Joseph Pantginis Dylan Dupuis Steven Seedhouse

Currently out of the existing stock ratings of VKTX, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Jul-2018

$106

$81.6 (334.43%)

$114

Buy Since 11-Sep-2024

$65

$40.6 (166.39%)

2 months 14 days ago
(11-Aug-2026)

0/3 (0%)

$31.2 (92.31%)

Buy Since 02-Dec-2024

$71

$46.6 (190.98%)

$71

3 months 18 days ago
(07-Jul-2026)

0/4 (0%)

$28.87 (68.53%)

Buy Since 28-Jun-2018

$100

$75.6 (309.84%)

$100

3 months 24 days ago
(01-Jul-2026)

13/23 (56.52%)

$62.52 (166.81%)

725

Buy Since 24-Jan-2022

$83

$44.96 (118.19%)

$75

4 months 28 days ago
(27-May-2026)

7/16 (43.75%)

$51.34 (162.16%)

257

Show more analysts

Please expand the browser size to see the chart

What is VKTX (Viking Therapeutics) average time for price targets to be met?

On average it took 402 days for the stock forecasts to be reached, with an average price target met ratio of 50.32%.

Which analyst most recently updated their price target on VKTX (Viking Therapeutics)?

Edward Nash

Which analyst has the most public recommendations on VKTX (Viking Therapeutics)?

Edward Nash works at CANACCORD and has 2 price targets and 2 ratings on VKTX

Which analyst is the currently most bullish on VKTX (Viking Therapeutics)?

Justin Zelin with the highest potential upside of $100.6

Which analyst is the currently most reserved on VKTX (Viking Therapeutics)?

James Lee with the lowest potential downside of -$42
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?